The deal size was increased to $180M in common stock from $150M in common stock. Jefferies, Goldman Sachs and Citi acted as joint book running managers for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTLA:
- Cathie Wood Makes $14M Bet on Alphabet Stock Ahead of Today’s Q1 Earnings, Buys the Dip in CRWV and Trims Bullish Stake
- Cathie Wood’s ARK Investment buys 596K shares of Intellia Therapeutics today
- Cathie Wood Offloads Rocket Lab Stock (RKLB) Despite 3% Jump, Buys the Dip in Intellia (NTLA)
- Intellia Therapeutics price target raised to $13 from $7 at Baird
- Intellia Therapeutics price target raised to $58 from $48 at Canaccord
